{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,21]],"date-time":"2026-09-21T18:08:28Z","timestamp":1790014108676,"version":"4.0.1"},"reference-count":147,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"16","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2007,10]]},"DOI":"10.1097\/qad.0b013e3282a4a64d","type":"journal-article","created":{"date-parts":[[2009,3,3]],"date-time":"2009-03-03T22:52:09Z","timestamp":1236120729000},"page":"2119-2129","source":"Crossref","is-referenced-by-count":194,"title":["HIV-associated cryptococcal meningitis"],"prefix":"10.1097","volume":"21","author":[{"given":"Joseph N","family":"Jarvis","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Thomas S","family":"Harrison","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","reference":[{"key":"R1-1-20210130","doi-asserted-by":"crossref","first-page":"1077","DOI":"10.1086\/507897","article-title":"Cryptococcus gattii infection: characteristics and epidemiology of cases identified in a South African province with high HIV seroprevalence, 2002\u20132004","volume":"43","author":"Morgan","year":"2006","journal-title":"Clin Infect Dis"},{"key":"R3-1-20210130","doi-asserted-by":"crossref","first-page":"178","DOI":"10.3201\/eid1301.060945","article-title":"Cryptococcus gattii risk for tourists visiting Vancouver Island, Canada","volume":"13","author":"Lindberg","year":"2007","journal-title":"Emerg Infect Dis"},{"key":"R5-1-20210130","doi-asserted-by":"crossref","first-page":"379","DOI":"10.1080\/mmy.38.5.379.383","article-title":"Possible primary ecological niche of Cryptococcus neoformans","volume":"38","author":"Lazera","year":"2000","journal-title":"Med Mycol"},{"key":"R6-1-20210130","doi-asserted-by":"crossref","first-page":"623","DOI":"10.1080\/13693780600860946","article-title":"Distribution of Cryptococcus gattii and Cryptococcus neoformans in decayed trunk wood of Syzygium cumini trees in north-western India","volume":"44","author":"Randhawa","year":"2006","journal-title":"Med Mycol"},{"key":"R7-1-20210130","doi-asserted-by":"crossref","first-page":"389","DOI":"10.1097\/00002030-198906000-00009","article-title":"Isolation of Cryptococcus neoformans from houses of AIDS-associated cryptococcosis patients in Bujumbura (Burundi)","volume":"3","author":"Swinne","year":"1989","journal-title":"AIDS"},{"key":"R8-1-20210130","first-page":"53","article-title":"Ecology of Cryptococcus neoformans in central Africa","volume":"54","author":"Swinne","year":"1994","journal-title":"Med Trop (Mars)"},{"key":"R9-1-20210130","doi-asserted-by":"crossref","first-page":"E66","DOI":"10.1542\/peds.107.5.e66","article-title":"Serologic evidence for Cryptococcus neoformans infection in early childhood","volume":"107","author":"Goldman","year":"2001","journal-title":"Pediatrics"},{"key":"R10-1-20210130","doi-asserted-by":"crossref","first-page":"7327","DOI":"10.1073\/pnas.93.14.7327","article-title":"Dimorphism and haploid fruiting in Cryptococcus neoformans: association with the alpha-mating type","volume":"93","author":"Wickes","year":"1996","journal-title":"Proc Natl Acad Sci USA"},{"key":"R11-1-20210130","first-page":"40","article-title":"Central nervous system infections in patients with systemic lupus erythematosus","volume":"32","author":"Hung","year":"2005","journal-title":"J Rheumatol"},{"key":"R12-1-20210130","doi-asserted-by":"crossref","first-page":"937","DOI":"10.1080\/0036554021000026969","article-title":"Cryptococcal meningitis and sarcoidosis","volume":"34","author":"Ross","year":"2002","journal-title":"Scand J Infect Dis"},{"key":"R13-1-20210130","doi-asserted-by":"crossref","first-page":"832","DOI":"10.1128\/IAI.68.2.832-838.2000","article-title":"Persistent Cryptococcus neoformans pulmonary infection in the rat is associated with intracellular parasitism, decreased inducible nitric oxide synthase expression, and altered antibody responsiveness to cryptococcal polysaccharide","volume":"68","author":"Goldman","year":"2000","journal-title":"Infect Immun"},{"key":"R14-1-20210130","doi-asserted-by":"crossref","first-page":"74","DOI":"10.1093\/infdis\/130.1.74","article-title":"Primary complex of Cryptococcus and pulmonary lymph nodes","volume":"130","author":"Salyer","year":"1974","journal-title":"J Infect Dis"},{"key":"R15-1-20210130","doi-asserted-by":"crossref","first-page":"3204","DOI":"10.1128\/JCM.37.10.3204-3209.1999","article-title":"Epidemiological evidence for dormant Cryptococcus neoformans infection","volume":"37","author":"Garcia-Hermoso","year":"1999","journal-title":"J Clin Microbiol"},{"key":"R16-1-20210130","doi-asserted-by":"crossref","first-page":"1354","DOI":"10.1056\/NEJM199305063281816","article-title":"Cryptococcal meningitis after unusual exposures to birds","volume":"328","author":"Fessel","year":"1993","journal-title":"N Engl J Med"},{"key":"R17-1-20210130","doi-asserted-by":"crossref","first-page":"1851","DOI":"10.1128\/JCM.44.5.1851-1852.2006","article-title":"Emergence of Cryptococcus gattii in a novel environment provides clues to its incubation period","volume":"44","author":"MacDougall","year":"2006","journal-title":"J Clin Microbiol"},{"key":"R18-1-20210130","doi-asserted-by":"crossref","first-page":"827","DOI":"10.1093\/clinids\/23.4.827","article-title":"Serum cryptococcal antigen in patients with AIDS","volume":"23","author":"Feldmesser","year":"1996","journal-title":"Clin Infect Dis"},{"key":"R19-1-20210130","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1056\/NEJM199201093260202","article-title":"Comparison of amphotericin B with fluconazole in the treatment of acute AIDS-associated cryptococcal meningitis. The NIAID Mycoses Study Group and the AIDS Clinical Trials Group","volume":"326","author":"Saag","year":"1992","journal-title":"N Engl J Med"},{"key":"R20-1-20210130","doi-asserted-by":"crossref","first-page":"1764","DOI":"10.1016\/S0140-6736(04)16301-0","article-title":"Combination antifungal therapies for HIV-associated cryptococcal meningitis: a randomised trial","volume":"363","author":"Brouwer","year":"2004","journal-title":"Lancet"},{"key":"R21-1-20210130","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1056\/NEJM199707033370103","article-title":"Treatment of cryptococcal meningitis associated with the acquired immunodeficiency syndrome. National Institute of Allergy and Infectious Diseases Mycoses Study Group and AIDS Clinical Trials Group","volume":"337","author":"van der Horst","year":"1997","journal-title":"N Engl J Med"},{"key":"R22-1-20210130","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1086\/313603","article-title":"Diagnosis and management of increased intracranial pressure in patients with AIDS and cryptococcal meningitis. The NIAID Mycoses Study Group and AIDS Cooperative Treatment Groups","volume":"30","author":"Graybill","year":"2000","journal-title":"Clin Infect Dis"},{"key":"R23-1-20210130","doi-asserted-by":"crossref","first-page":"194","DOI":"10.1093\/clinids\/23.1.194","article-title":"Polysaccharide antigen in brain tissue of AIDS patients with cryptococcal meningitis","volume":"23","author":"Lee","year":"1996","journal-title":"Clin Infect Dis"},{"key":"R24-1-20210130","first-page":"1267","article-title":"Immunohistochemical localization of capsular polysaccharide antigen in the central nervous system cells in cryptococcal meningoencephalitis","volume":"148","author":"Lee","year":"1996","journal-title":"Am J Pathol"},{"key":"R25-1-20210130","doi-asserted-by":"crossref","first-page":"839","DOI":"10.1016\/S0046-8177(96)90459-1","article-title":"Pathology of cryptococcal meningoencephalitis: analysis of 27 patients with pathogenetic implications","volume":"27","author":"Lee","year":"1996","journal-title":"Hum Pathol"},{"key":"R26-1-20210130","first-page":"561","article-title":"Demonstration of Cryptococcus neoformans in a fatal meningeal disease in the Congo","volume":"42","author":"Molez","year":"1982","journal-title":"Med Trop (Mars)"},{"key":"R27-1-20210130","doi-asserted-by":"crossref","first-page":"273","DOI":"10.4269\/ajtmh.1998.58.273","article-title":"The historical question of acquired immunodeficiency syndrome in the 1960s in the Congo River basin area in relation to cryptococcal meningitis","volume":"58","author":"Molez","year":"1998","journal-title":"Am J Trop Med Hyg"},{"key":"R28-1-20210130","first-page":"507","article-title":"Clinical and epidemiologic aspects of cryptococcosis in Kinshasa. Apropos of 15 personal cases","volume":"42","author":"Lamey","year":"1982","journal-title":"Med Trop (Mars)"},{"key":"R29-1-20210130","first-page":"57","article-title":"Isolation of saprophytic Cryptococcus neoformans var. neoformans in Kinshasa, Zaire","volume":"66","author":"Swinne","year":"1986","journal-title":"Ann Soc Belg Med Trop"},{"key":"R30-1-20210130","doi-asserted-by":"crossref","first-page":"642","DOI":"10.1016\/S0140-6736(83)91808-1","article-title":"Acquired immune deficiency syndrome in Black Africans","volume":"1","author":"Clumeck","year":"1983","journal-title":"Lancet"},{"key":"R31-1-20210130","doi-asserted-by":"crossref","first-page":"700","DOI":"10.1016\/S0140-6736(83)91985-2","article-title":"Acquired immunodeficiency syndrome in France","volume":"1","author":"Brunet","year":"1983","journal-title":"Lancet"},{"key":"R32-1-20210130","doi-asserted-by":"crossref","first-page":"775","DOI":"10.1056\/NEJM198303313081310","article-title":"Multiple opportunistic infection due to AIDS in a previously healthy black woman from Zaire","volume":"308","author":"Offenstadt","year":"1983","journal-title":"N Engl J Med"},{"key":"R33-1-20210130","doi-asserted-by":"crossref","first-page":"925","DOI":"10.1016\/S0140-6736(83)91349-1","article-title":"AIDS and cryptococcosis (Zaire, 1977)","volume":"1","author":"Vandepitte","year":"1983","journal-title":"Lancet"},{"key":"R34-1-20210130","doi-asserted-by":"crossref","first-page":"632","DOI":"10.1086\/514083","article-title":"Effect of the human immunodeficiency virus epidemic on mortality from opportunistic infections in the United States in 1993","volume":"176","author":"Selik","year":"1997","journal-title":"J Infect Dis"},{"key":"R35-1-20210130","doi-asserted-by":"crossref","first-page":"673","DOI":"10.1097\/00002030-199705000-00016","article-title":"Incidence and factors associated with extrapulmonary cryptococcosis among persons with HIV infection in Los Angeles County","volume":"11","author":"Sorvillo","year":"1997","journal-title":"AIDS"},{"key":"R36-1-20210130","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1097\/00042560-199709010-00006","article-title":"Trends in incidence of AIDS illnesses in Australia from 1983 to 1994: the Australian AIDS cohort","volume":"16","author":"Dore","year":"1997","journal-title":"J Acquir Immune Defic Syndr Hum Retrovirol"},{"key":"R37-1-20210130","doi-asserted-by":"crossref","first-page":"794","DOI":"10.1056\/NEJM198909213211205","article-title":"Infections with Cryptococcus neoformans in the acquired immunodeficiency syndrome","volume":"321","author":"Chuck","year":"1989","journal-title":"N Engl J Med"},{"key":"R38-1-20210130","doi-asserted-by":"crossref","first-page":"449","DOI":"10.1086\/314606","article-title":"Cryptococcosis: population-based multistate active surveillance and risk factors in human immunodeficiency virus-infected persons. Cryptococcal Active Surveillance Group","volume":"179","author":"Hajjeh","year":"1999","journal-title":"J Infect Dis"},{"key":"R39-1-20210130","doi-asserted-by":"crossref","first-page":"499","DOI":"10.1086\/313992","article-title":"Epidemiology and host- and variety-dependent characteristics of infection due to Cryptococcus neoformans in Australia and New Zealand. Australasian Cryptococcal Study Group","volume":"31","author":"Chen","year":"2000","journal-title":"Clin Infect Dis"},{"issue":"Suppl 1","key":"R40-1-20210130","doi-asserted-by":"crossref","first-page":"S5","DOI":"10.1086\/313843","article-title":"Epidemiology of human immunodeficiency virus-associated opportunistic infections in the United States in the era of highly active antiretroviral therapy","volume":"30","author":"Kaplan","year":"2000","journal-title":"Clin Infect Dis"},{"key":"R41-1-20210130","doi-asserted-by":"crossref","first-page":"789","DOI":"10.1086\/368091","article-title":"The changing epidemiology of cryptococcosis: an update from population-based active surveillance in 2 large metropolitan areas, 1992\u20132000","volume":"36","author":"Mirza","year":"2003","journal-title":"Clin Infect Dis"},{"key":"R42-1-20210130","doi-asserted-by":"crossref","first-page":"652","DOI":"10.1086\/367655","article-title":"Review of human immunodeficiency virus type 1-related opportunistic infections in sub-Saharan Africa","volume":"36","author":"Holmes","year":"2003","journal-title":"Clin Infect Dis"},{"key":"R43-1-20210130","doi-asserted-by":"crossref","first-page":"955","DOI":"10.1086\/319348","article-title":"Clinical presentation and risk behaviors of patients with acquired immunodeficiency syndrome in Thailand, 1994\u20131998: regional variation and temporal trends","volume":"32","author":"Chariyalertsak","year":"2001","journal-title":"Clin Infect Dis"},{"key":"R44-1-20210130","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1086\/313910","article-title":"Bacterial meningitis in Malawian adults: pneumococcal disease is common, severe, and seasonal","volume":"31","author":"Gordon","year":"2000","journal-title":"Clin Infect Dis"},{"key":"R45-1-20210130","doi-asserted-by":"crossref","first-page":"387","DOI":"10.1016\/j.ijid.2005.07.004","article-title":"Primary and opportunistic pathogens associated with meningitis in adults in Bangui, Central African Republic, in relation to human immunodeficiency virus serostatus","volume":"10","author":"Bekondi","year":"2006","journal-title":"Int J Infect Dis"},{"key":"R46-1-20210130","doi-asserted-by":"crossref","first-page":"1401","DOI":"10.1097\/00002030-200007070-00013","article-title":"Impact of HIV infection on meningitis in Harare, Zimbabwe: a prospective study of 406 predominantly adult patients","volume":"14","author":"Hakim","year":"2000","journal-title":"AIDS"},{"key":"R47-1-20210130","doi-asserted-by":"crossref","first-page":"698","DOI":"10.1093\/ije\/27.4.698","article-title":"Causes of death in a rural, population-based human immunodeficiency virus type 1 (HIV-1) natural history cohort in Uganda","volume":"27","author":"Okongo","year":"1998","journal-title":"Int J Epidemiol"},{"key":"R48-1-20210130","doi-asserted-by":"crossref","first-page":"1031","DOI":"10.1097\/00002030-200205030-00009","article-title":"Cryptococcal infection in a cohort of HIV-1-infected Ugandan adults","volume":"16","author":"French","year":"2002","journal-title":"AIDS"},{"key":"R49-1-20210130","doi-asserted-by":"crossref","first-page":"1251","DOI":"10.1086\/339540","article-title":"Morbidity and mortality in South African gold miners: impact of untreated disease due to human immunodeficiency virus","volume":"34","author":"Corbett","year":"2002","journal-title":"Clin Infect Dis"},{"key":"R50-1-20210130","first-page":"117","article-title":"AIDS at Siriraj Hospital during 1985\u20131993","volume":"11","author":"Suwanagool","year":"1994","journal-title":"J Infect Dis Antimicrob Agents"},{"key":"R51-1-20210130","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1086\/344756","article-title":"Natural history of human immunodeficiency virus disease in southern India","volume":"36","author":"Kumarasamy","year":"2003","journal-title":"Clin Infect Dis"},{"key":"R52-1-20210130","doi-asserted-by":"crossref","first-page":"299","DOI":"10.1590\/S0036-46652003000600001","article-title":"Cryptococcosis: a review of the Brazilian experience for the disease","volume":"45","author":"Pappalardo","year":"2003","journal-title":"Rev Inst Med Trop Sao Paulo"},{"key":"R53-1-20210130","doi-asserted-by":"crossref","first-page":"1569","DOI":"10.1097\/00002030-199312000-00005","article-title":"The mortality and pathology of HIV infection in a west African city","volume":"7","author":"Lucas","year":"1993","journal-title":"AIDS"},{"key":"R54-1-20210130","doi-asserted-by":"crossref","first-page":"2183","DOI":"10.1097\/01.aids.0000252060.80704.68","article-title":"Long-term outcome of AIDS-associated cryptococcosis in the era of combination antiretroviral therapy","volume":"20","author":"Lortholary","year":"2006","journal-title":"AIDS"},{"key":"R55-1-20210130","doi-asserted-by":"crossref","first-page":"82","DOI":"10.1086\/515074","article-title":"Early mycological treatment failure in AIDS-associated cryptococcal meningitis","volume":"28","author":"Robinson","year":"1999","journal-title":"Clin Infect Dis"},{"key":"R56-1-20210130","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1136\/pmj.76.892.85","article-title":"Cryptococcosis in AIDS","volume":"76","author":"Imwidthaya","year":"2000","journal-title":"Postgrad Med J"},{"key":"R57-1-20210130","doi-asserted-by":"crossref","first-page":"769","DOI":"10.1136\/pgmj.77.914.769","article-title":"Clinical presentation, natural history, and cumulative death rates of 230 adults with primary cryptococcal meningitis in Zambian AIDS patients treated under local conditions","volume":"77","author":"Mwaba","year":"2001","journal-title":"Postgrad Med J"},{"key":"R58-1-20210130","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1016\/S0163-4453(94)94161-0","article-title":"Cryptococcal meningitis in Lilongwe and Blantyre, Malawi","volume":"28","author":"Maher","year":"1994","journal-title":"J Infect"},{"key":"R59-1-20210130","doi-asserted-by":"crossref","first-page":"284","DOI":"10.1086\/516298","article-title":"Cryptococcal meningitis in human immunodeficiency virus-infected patients in Harare, Zimbabwe","volume":"26","author":"Heyderman","year":"1998","journal-title":"Clin Infect Dis"},{"key":"R60-1-20210130","doi-asserted-by":"crossref","first-page":"76","DOI":"10.1086\/518607","article-title":"Fungal burden, early fungicidal activity, and outcome in cryptococcal meningitis in antiretroviral-naive or -experienced patients treated with amphotericin B or fluconazole","volume":"45","author":"Bicanic","year":"2007","journal-title":"Clin Infect Dis"},{"key":"R61-1-20210130","doi-asserted-by":"crossref","first-page":"710","DOI":"10.1086\/313757","article-title":"Practice guidelines for the management of cryptococcal disease. Infectious Diseases Society of America","volume":"30","author":"Saag","year":"2000","journal-title":"Clin Infect Dis"},{"key":"R62-1-20210130","doi-asserted-by":"crossref","first-page":"230","DOI":"10.1016\/S1473-3099(03)00580-2","article-title":"British Society for Medical Mycology proposed standards of care for patients with invasive fungal infections","volume":"3","author":"Denning","year":"2003","journal-title":"Lancet Infect Dis"},{"key":"R63-1-20210130","doi-asserted-by":"crossref","first-page":"2389","DOI":"10.1001\/archinte.1988.00380110049010","article-title":"Prevention of amphotericin B-induced renal impairment. A review on the use of sodium supplementation","volume":"148","author":"Branch","year":"1988","journal-title":"Arch Intern Med"},{"key":"R64-1-20210130","doi-asserted-by":"crossref","first-page":"916","DOI":"10.1182\/blood-2005-06-2564","article-title":"Amphotericin B blunts erythropoietin response to hypoxia by reinforcing FIH-mediated repression of HIF-1","volume":"107","author":"Yeo","year":"2006","journal-title":"Blood"},{"key":"R65-1-20210130","doi-asserted-by":"crossref","first-page":"340","DOI":"10.7326\/0003-4819-61-2-340","article-title":"Amphotericin B toxicity: general side effects","volume":"61","author":"Utz","year":"1964","journal-title":"Ann Intern Med"},{"key":"R66-1-20210130","doi-asserted-by":"crossref","first-page":"343","DOI":"10.7326\/0003-4819-61-2-343","article-title":"Amphotericin B toxicity: anemia","volume":"61","author":"Brandiss","year":"1964","journal-title":"Ann Intern Med"},{"key":"R67-1-20210130","doi-asserted-by":"crossref","first-page":"663","DOI":"10.1001\/jama.1964.03070090013003","article-title":"Anemia induced by Amphotericin B","volume":"189","author":"Brandriss","year":"1964","journal-title":"JAMA"},{"key":"R68-1-20210130","doi-asserted-by":"crossref","first-page":"1038","DOI":"10.1128\/AAC.01188-06","article-title":"Oral versus intravenous flucytosine in patients with human immunodeficiency virus-associated cryptococcal meningitis","volume":"51","author":"Brouwer","year":"2007","journal-title":"Antimicrob Agents Chemother"},{"key":"R69-1-20210130","doi-asserted-by":"crossref","first-page":"938","DOI":"10.1128\/AAC.44.4.938-942.2000","article-title":"In vivo characterization of the pharmacodynamics of flucytosine in a neutropenic murine disseminated candidiasis model","volume":"44","author":"Andes","year":"2000","journal-title":"Antimicrob Agents Chemother"},{"key":"R70-1-20210130","doi-asserted-by":"crossref","first-page":"1003","DOI":"10.1093\/clind\/15.6.1003","article-title":"Evolving role of flucytosine in immunocompromised patients: new insights into safety, pharmacokinetics, and antifungal therapy","volume":"15","author":"Francis","year":"1992","journal-title":"Clin Infect Dis"},{"key":"R71-1-20210130","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1016\/S0732-8893(99)00125-X","article-title":"In vitro pharmacodynamic characteristics of flucytosine determined by time-kill methods","volume":"36","author":"Lewis","year":"2000","journal-title":"Diagn Microbiol Infect Dis"},{"key":"R72-1-20210130","doi-asserted-by":"crossref","first-page":"1463","DOI":"10.1097\/00002030-199712000-00010","article-title":"Liposomal amphotericin B (AmBisome) compared with amphotericin B both followed by oral fluconazole in the treatment of AIDS-associated cryptococcal meningitis","volume":"11","author":"Leenders","year":"1997","journal-title":"AIDS"},{"key":"R74-1-20210130","doi-asserted-by":"crossref","first-page":"183","DOI":"10.7326\/0003-4819-113-3-183","article-title":"Fluconazole compared with amphotericin B plus flucytosine for cryptococcal meningitis in AIDS. A randomized trial","volume":"113","author":"Larsen","year":"1990","journal-title":"Ann Intern Med"},{"key":"R75-1-20210130","doi-asserted-by":"crossref","first-page":"118","DOI":"10.1186\/1471-2334-6-118","article-title":"Outcome of AIDS-associated cryptococcal meningitis initially treated with 200 mg\/day or 400 mg\/day of fluconazole","volume":"6","author":"Schaars","year":"2006","journal-title":"BMC Infect Dis"},{"key":"R76-1-20210130","doi-asserted-by":"crossref","first-page":"1362","DOI":"10.1086\/516372","article-title":"Combination therapy with fluconazole and flucytosine for cryptococcal meningitis in Ugandan patients with AIDS","volume":"26","author":"Mayanja-Kizza","year":"1998","journal-title":"Clin Infect Dis"},{"key":"R77-1-20210130","doi-asserted-by":"crossref","first-page":"1069","DOI":"10.1086\/507895","article-title":"Symptomatic relapse of HIV-associated cryptococcal meningitis after initial fluconazole monotherapy: the role of fluconazole resistance and immune reconstitution","volume":"43","author":"Bicanic","year":"2006","journal-title":"Clin Infect Dis"},{"key":"R78-1-20210130","doi-asserted-by":"crossref","first-page":"1216","DOI":"10.1093\/infdis\/173.5.1216","article-title":"Treatment of experimental cryptococcal meningitis with fluconazole: impact of dose and addition of flucytosine on mycologic and pathophysiologic outcome","volume":"173","author":"Kartalija","year":"1996","journal-title":"J Infect Dis"},{"key":"R79-1-20210130","doi-asserted-by":"crossref","first-page":"599","DOI":"10.1093\/infdis\/172.2.599","article-title":"Safety, plasma concentrations, and efficacy of high-dose fluconazole in invasive mold infections","volume":"172","author":"Anaissie","year":"1995","journal-title":"J Infect Dis"},{"key":"R81-1-20210130","doi-asserted-by":"crossref","first-page":"238","DOI":"10.1093\/infdis\/170.1.238","article-title":"High-dose fluconazole for treatment of cryptococcal disease in patients with human immunodeficiency virus infection. The California Collaborative Treatment Group","volume":"170","author":"Haubrich","year":"1994","journal-title":"J Infect Dis"},{"key":"R82-1-20210130","doi-asserted-by":"crossref","first-page":"838","DOI":"10.1093\/clinids\/22.5.838","article-title":"High-dose fluconazole therapy for cryptococcal meningitis in patients with AIDS","volume":"22","author":"Menichetti","year":"1996","journal-title":"Clin Infect Dis"},{"key":"R83-1-20210130","doi-asserted-by":"crossref","first-page":"726","DOI":"10.1128\/AAC.35.4.726","article-title":"Combined therapy with fluconazole and flucytosine in murine cryptococcal meningitis","volume":"35","author":"Allendoerfer","year":"1991","journal-title":"Antimicrob Agents Chemother"},{"key":"R84-1-20210130","doi-asserted-by":"crossref","first-page":"1589","DOI":"10.1128\/AAC.41.7.1589","article-title":"Effect of severity of meningitis on fungicidal activity of flucytosine combined with fluconazole in a murine model of cryptococcal meningitis","volume":"41","author":"Ding","year":"1997","journal-title":"Antimicrob Agents Chemother"},{"key":"R85-1-20210130","doi-asserted-by":"crossref","first-page":"741","DOI":"10.1093\/clinids\/19.4.741","article-title":"Fluconazole combined with flucytosine for treatment of cryptococcal meningitis in patients with AIDS","volume":"19","author":"Larsen","year":"1994","journal-title":"Clin Infect Dis"},{"key":"R86-1-20210130","doi-asserted-by":"crossref","first-page":"580","DOI":"10.1056\/NEJM199102283240902","article-title":"A placebo-controlled trial of maintenance therapy with fluconazole after treatment of cryptococcal meningitis in the acquired immunodeficiency syndrome. California Collaborative Treatment Group","volume":"324","author":"Bozzette","year":"1991","journal-title":"N Engl J Med"},{"key":"R87-1-20210130","doi-asserted-by":"crossref","first-page":"793","DOI":"10.1056\/NEJM199203193261203","article-title":"A controlled trial of fluconazole or amphotericin B to prevent relapse of cryptococcal meningitis in patients with the acquired immunodeficiency syndrome. The NIAID AIDS Clinical Trials Group and Mycoses Study Group","volume":"326","author":"Powderly","year":"1992","journal-title":"N Engl J Med"},{"key":"R88-1-20210130","doi-asserted-by":"crossref","first-page":"291","DOI":"10.1086\/515110","article-title":"A comparison of itraconazole versus fluconazole as maintenance therapy for AIDS-associated cryptococcal meningitis. National Institute of Allergy and Infectious Diseases Mycoses Study Group","volume":"28","author":"Saag","year":"1999","journal-title":"Clin Infect Dis"},{"key":"R89-1-20210130","doi-asserted-by":"crossref","first-page":"1179","DOI":"10.1086\/339680","article-title":"A pilot study of the discontinuation of antifungal therapy for disseminated cryptococcal disease in patients with acquired immunodeficiency syndrome, following immunologic response to antiretroviral therapy","volume":"185","author":"Aberg","year":"2002","journal-title":"J Infect Dis"},{"key":"R90-1-20210130","doi-asserted-by":"crossref","first-page":"1329","DOI":"10.1086\/374849","article-title":"Discontinuation of secondary prophylaxis for cryptococcal meningitis in human immunodeficiency virus-infected patients treated with highly active antiretroviral therapy: a prospective, multicenter, randomized study","volume":"36","author":"Vibhagool","year":"2003","journal-title":"Clin Infect Dis"},{"key":"R91-1-20210130","doi-asserted-by":"crossref","first-page":"565","DOI":"10.1086\/381261","article-title":"Discontinuation of maintenance therapy for cryptococcal meningitis in patients with AIDS treated with highly active antiretroviral therapy: an international observational study","volume":"38","author":"Mussini","year":"2004","journal-title":"Clin Infect Dis"},{"key":"R92-1-20210130","doi-asserted-by":"crossref","first-page":"267","DOI":"10.1016\/0002-9343(91)90126-I","article-title":"Elevated cerebrospinal fluid pressures in patients with cryptococcal meningitis and acquired immunodeficiency syndrome","volume":"91","author":"Denning","year":"1991","journal-title":"Am J Med"},{"key":"R93-1-20210130","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1097\/00005792-199307000-00001","article-title":"Catastrophic visual loss due to Cryptococcus neoformans meningitis","volume":"72","author":"Rex","year":"1993","journal-title":"Medicine (Baltimore)"},{"key":"R95-1-20210130","doi-asserted-by":"crossref","first-page":"1431","DOI":"10.1097\/01.qai.0000137411.23705.7a","article-title":"Dexamethasone downregulates Cryptococcus neoformans-induced vascular endothelial growth factor production: a role for corticosteroids in cryptococcal meningitis?","volume":"37","author":"Hoepelman","year":"2004","journal-title":"J Acquir Immune Defic Syndr"},{"key":"R96-1-20210130","doi-asserted-by":"crossref","first-page":"1310","DOI":"10.1086\/423849","article-title":"Intrathecal production and secretion of vascular endothelial growth factor during cryptococcal meningitis","volume":"190","author":"Coenjaerts","year":"2004","journal-title":"J Infect Dis"},{"key":"R97-1-20210130","doi-asserted-by":"crossref","first-page":"1790","DOI":"10.1086\/421272","article-title":"Management of cryptococcal meningitis with extremely high intracranial pressure in HIV-infected patients","volume":"38","author":"Sun","year":"2004","journal-title":"Clin Infect Dis"},{"key":"R98-1-20210130","doi-asserted-by":"crossref","first-page":"629","DOI":"10.1086\/515161","article-title":"Treatment of hydrocephalus secondary to cryptococcal meningitis by use of shunting","volume":"28","author":"Park","year":"1999","journal-title":"Clin Infect Dis"},{"key":"R99-1-20210130","doi-asserted-by":"crossref","first-page":"e221","DOI":"10.1016\/j.jinf.2005.02.010","article-title":"Lumbar drainage for control of raised cerebrospinal fluid pressure in cryptococcal meningitis: case report and review","volume":"51","author":"Macsween","year":"2005","journal-title":"J Infect"},{"key":"R100-1-20210130","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1097\/00042560-199802010-00006","article-title":"Management of elevated intracranial pressure in patients with cryptococcal meningitis","volume":"17","author":"Fessler","year":"1998","journal-title":"J Acquir Immune Defic Syndr Hum Retrovirol"},{"key":"R101-1-20210130","doi-asserted-by":"crossref","first-page":"468","DOI":"10.1136\/jnnp.67.4.468","article-title":"Bacterial meningitis associated with lumbar drains: a retrospective cohort study","volume":"67","author":"Coplin","year":"1999","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"R103-1-20210130","doi-asserted-by":"crossref","first-page":"769","DOI":"10.1086\/342299","article-title":"A randomized, double-blind, placebo-controlled trial of acetazolamide for the treatment of elevated intracranial pressure in cryptococcal meningitis","volume":"35","author":"Newton","year":"2002","journal-title":"Clin Infect Dis"},{"key":"R104-1-20210130","doi-asserted-by":"crossref","first-page":"1639","DOI":"10.1086\/503903","article-title":"Immune reconstitution syndrome in HIV: validating a case definition and identifying clinical predictors in persons initiating antiretroviral therapy","volume":"42","author":"Robertson","year":"2006","journal-title":"Clin Infect Dis"},{"key":"R105-1-20210130","doi-asserted-by":"crossref","first-page":"418","DOI":"10.1086\/499356","article-title":"Incidence and risk factors for immune reconstitution inflammatory syndrome in an ethnically diverse HIV type 1-infected cohort","volume":"42","author":"Ratnam","year":"2006","journal-title":"Clin Infect Dis"},{"key":"R106-1-20210130","doi-asserted-by":"crossref","first-page":"361","DOI":"10.1016\/S1473-3099(05)70140-7","article-title":"Immune reconstitution disease associated with mycobacterial infections in HIV-infected individuals receiving antiretrovirals","volume":"5","author":"Lawn","year":"2005","journal-title":"Lancet Infect Dis"},{"key":"R107-1-20210130","doi-asserted-by":"crossref","first-page":"1049","DOI":"10.1086\/428618","article-title":"The role of immune reconstitution inflammatory syndrome in AIDS-related Cryptococcus neoformans disease in the era of highly active antiretroviral therapy","volume":"40","author":"Shelburne","year":"2005","journal-title":"Clin Infect Dis"},{"key":"R108-1-20210130","doi-asserted-by":"crossref","first-page":"1043","DOI":"10.1097\/01.aids.0000174450.70874.30","article-title":"Incidence and risk factors of immune reconstitution inflammatory syndrome complicating HIV-associated cryptococcosis in France","volume":"19","author":"Lortholary","year":"2005","journal-title":"AIDS"},{"key":"R109-1-20210130","doi-asserted-by":"crossref","first-page":"2050","DOI":"10.1097\/01.aids.0000191232.16111.f9","article-title":"Cryptococcocal immune reconstitution disease: a major cause of early mortality in a South African antiretroviral programme","volume":"19","author":"Lawn","year":"2005","journal-title":"AIDS"},{"key":"R110-1-20210130","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1053\/jinf.2002.1052","article-title":"Mediastinitis due to cryptococcal infection: a new clinical entity in the HAART era","volume":"45","author":"Trevenzoli","year":"2002","journal-title":"J Infect"},{"key":"R111-1-20210130","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1023\/A:1007156027134","article-title":"The changing face of AIDS-related opportunism: cryptococcosis in the highly active antiretroviral therapy (HAART) era. Case reports and literature review","volume":"148","author":"Manfredi","year":"1999","journal-title":"Mycopathologia"},{"key":"R112-1-20210130","doi-asserted-by":"crossref","first-page":"349","DOI":"10.1097\/00002030-200401230-00034","article-title":"Multiple cerebral cryptococcomas associated with immune reconstitution in HIV-1 infection","volume":"18","author":"Cattelan","year":"2004","journal-title":"AIDS"},{"key":"R113-1-20210130","doi-asserted-by":"crossref","first-page":"e128","DOI":"10.1086\/344467","article-title":"Immune reconstitution cryptococcosis after initiation of successful highly active antiretroviral therapy","volume":"35","author":"Jenny-Avital","year":"2002","journal-title":"Clin Infect Dis"},{"key":"R114-1-20210130","doi-asserted-by":"crossref","first-page":"1491","DOI":"10.1097\/00002030-199812000-00011","article-title":"HIV combination therapy: partial immune restitution unmasking latent cryptococcal infection","volume":"12","author":"Woods","year":"1998","journal-title":"AIDS"},{"key":"R115-1-20210130","first-page":"67","article-title":"The immune reconstitution inflammatory syndrome","volume":"5","author":"Shelburne","year":"2003","journal-title":"AIDS Rev"},{"key":"R116-1-20210130","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1016\/j.jinf.2005.04.022","article-title":"Raised intracranial pressure complicating cryptococcal meningitis: immune reconstitution inflammatory syndrome or recurrent cryptococcal disease?","volume":"51","author":"York","year":"2005","journal-title":"J Infect"},{"key":"R117-1-20210130","doi-asserted-by":"crossref","first-page":"2141","DOI":"10.1097\/01.aids.0000194802.89540.e1","article-title":"Early mortality among adults accessing a community-based antiretroviral service in South Africa: implications for programme design","volume":"19","author":"Lawn","year":"2005","journal-title":"AIDS"},{"key":"R118-1-20210130","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1097\/00005792-200205000-00005","article-title":"Immune reconstitution inflammatory syndrome: emergence of a unique syndrome during highly active antiretroviral therapy","volume":"81","author":"Shelburne","year":"2002","journal-title":"Medicine (Baltimore)"},{"key":"R119-1-20210130","doi-asserted-by":"crossref","first-page":"1223","DOI":"10.1097\/00002030-200405210-00023","article-title":"Relapsing meningitis caused by persistent cryptococcal antigens and immune reconstitution after the initiation of highly active antiretroviral therapy","volume":"18","author":"Boelaert","year":"2004","journal-title":"AIDS"},{"key":"R120-1-20210130","doi-asserted-by":"crossref","first-page":"140","DOI":"10.1111\/j.1468-1293.2004.00201.x","article-title":"A multicentre, randomized, double-blind, placebo-controlled trial of primary cryptococcal meningitis prophylaxis in HIV-infected patients with severe immune deficiency","volume":"5","author":"Chetchotisakd","year":"2004","journal-title":"HIV Med"},{"key":"R122-1-20210130","doi-asserted-by":"crossref","first-page":"411","DOI":"10.1097\/00126334-200307010-00019","article-title":"Systematic screening of cryptococcal antigenemia in HIV-positive adults in Uganda","volume":"33","author":"Tassie","year":"2003","journal-title":"J Acquir Immune Defic Syndr"},{"key":"R123-1-20210130","doi-asserted-by":"crossref","first-page":"697","DOI":"10.3109\/00365549109024296","article-title":"Low yield of screening for cryptococcal antigen by latex agglutination assay on serum and cerebrospinal fluid from Danish patients with AIDS or ARC","volume":"23","author":"Hoffmann","year":"1991","journal-title":"Scand J Infect Dis"},{"key":"R124-1-20210130","doi-asserted-by":"crossref","first-page":"530","DOI":"10.1016\/S1473-3099(05)70197-3","article-title":"Antiretroviral roll-out, antifungal roll-back: access to treatment for cryptococcal meningitis","volume":"5","author":"Bicanic","year":"2005","journal-title":"Lancet Infect Dis"},{"key":"R125-1-20210130","doi-asserted-by":"crossref","first-page":"1122","DOI":"10.1086\/374557","article-title":"Voriconazole treatment for less-common, emerging, or refractory fungal infections","volume":"36","author":"Perfect","year":"2003","journal-title":"Clin Infect Dis"},{"key":"R126-1-20210130","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1016\/S0732-8893(02)00361-9","article-title":"Antifungal activities of fluconazole, caspofungin (MK0991), and anidulafungin (LY 303366) alone and in combination against Candida spp. and Cryptococcus neoformans via time-kill methods","volume":"43","author":"Roling","year":"2002","journal-title":"Diagn Microbiol Infect Dis"},{"key":"R127-1-20210130","doi-asserted-by":"crossref","first-page":"952","DOI":"10.1128\/AAC.49.3.952-958.2005","article-title":"Phase I evaluation of the safety and pharmacokinetics of murine-derived anticryptococcal antibody 18B7 in subjects with treated cryptococcal meningitis","volume":"49","author":"Larsen","year":"2005","journal-title":"Antimicrob Agents Chemother"},{"key":"R128-1-20210130","doi-asserted-by":"crossref","first-page":"2208","DOI":"10.1128\/AAC.47.7.2208-2216.2003","article-title":"Preclinical assessment of the efficacy of mycograb, a human recombinant antibody against fungal HSP90","volume":"47","author":"Matthews","year":"2003","journal-title":"Antimicrob Agents Chemother"},{"key":"R129-1-20210130","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1016\/j.diagmicrobio.2004.08.013","article-title":"Evaluation of Mycograb, amphotericin B, caspofungin, and fluconazole in combination against Cryptococcus neoformans by checkerboard and time-kill methodologies","volume":"51","author":"Nooney","year":"2005","journal-title":"Diagn Microbiol Infect Dis"},{"key":"R130-1-20210130","doi-asserted-by":"crossref","first-page":"1746","DOI":"10.4049\/jimmunol.174.3.1746","article-title":"IFN-gamma at the site of infection determines rate of clearance of infection in cryptococcal meningitis","volume":"174","author":"Siddiqui","year":"2005","journal-title":"J Immunol"},{"key":"R131-1-20210130","doi-asserted-by":"crossref","first-page":"2185","DOI":"10.1086\/420829","article-title":"Recombinant interferon-gamma 1b as adjunctive therapy for AIDS-related acute cryptococcal meningitis","volume":"189","author":"Pappas","year":"2004","journal-title":"J Infect Dis"},{"key":"R132-1-20210130","doi-asserted-by":"crossref","first-page":"525","DOI":"10.1111\/j.1567-1364.2006.00073.x","article-title":"Towards a vaccine for Cryptococcus neoformans: principles and caveats","volume":"6","author":"Datta","year":"2006","journal-title":"FEMS Yeast Res"},{"key":"R133-1-20210130","doi-asserted-by":"crossref","first-page":"1405","DOI":"10.1084\/jem.20030109","article-title":"Vaccine immunity to pathogenic fungi overcomes the requirement for CD4 help in exogenous antigen presentation to CD8+ T cells: implications for vaccine development in immune-deficient hosts","volume":"197","author":"Wuthrich","year":"2003","journal-title":"J Exp Med"},{"key":"R134-1-20210130","doi-asserted-by":"crossref","first-page":"775","DOI":"10.1016\/S1473-3099(05)70297-8","article-title":"Posaconazole: a broad-spectrum triazole antifungal","volume":"5","author":"Torres","year":"2005","journal-title":"Lancet Infect Dis"},{"key":"R135-1-20210130","doi-asserted-by":"crossref","first-page":"2163","DOI":"10.1128\/JCM.43.5.2163-2167.2005","article-title":"Global trends in the antifungal susceptibility of Cryptococcus neoformans (1990 to 2004)","volume":"43","author":"Pfaller","year":"2005","journal-title":"J Clin Microbiol"},{"key":"R136-1-20210130","doi-asserted-by":"crossref","first-page":"226","DOI":"10.1128\/AAC.44.1.226-229.2000","article-title":"In vitro activities of the new antifungal triazole SCH 56592 against common and emerging yeast pathogens","volume":"44","author":"Barchiesi","year":"2000","journal-title":"Antimicrob Agents Chemother"},{"key":"R137-1-20210130","doi-asserted-by":"crossref","first-page":"2862","DOI":"10.1128\/AAC.45.10.2862-2864.2001","article-title":"In vitro activities of posaconazole (Sch 56592) compared with those of itraconazole and fluconazole against 3685 clinical isolates of Candida spp. and Cryptococcus neoformans","volume":"45","author":"Pfaller","year":"2001","journal-title":"Antimicrob Agents Chemother"},{"key":"R138-1-20210130","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1016\/j.diagmicrobio.2003.09.008","article-title":"In vitro activities of voriconazole, posaconazole, and fluconazole against 4169 clinical isolates of Candida spp. and Cryptococcus neoformans collected during 2001 and 2002 in the ARTEMIS global antifungal surveillance program","volume":"48","author":"Pfaller","year":"2004","journal-title":"Diagn Microbiol Infect Dis"},{"key":"R139-1-20210130","first-page":"121","article-title":"In vitro antifungal activities of anidulafungin and micafungin, licensed agents and the investigational triazole posaconazole as determined by NCCLS methods for 12 052 fungal isolates: review of the literature","volume":"20","author":"Espinel-Ingroff","year":"2003","journal-title":"Rev Iberoam Micol"},{"key":"R140-1-20210130","doi-asserted-by":"crossref","first-page":"1910","DOI":"10.1128\/AAC.40.8.1910","article-title":"In vitro and in vivo efficacies of the azole SCH56592 against Cryptococcus neoformans","volume":"40","author":"Perfect","year":"1996","journal-title":"Antimicrob Agents Chemother"},{"key":"R141-1-20210130","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1128\/AAC.43.1.169","article-title":"In vitro activities of voriconazole, fluconazole, and itraconazole against 566 clinical isolates of Cryptococcus neoformans from the United States and Africa","volume":"43","author":"Pfaller","year":"1999","journal-title":"Antimicrob Agents Chemother"},{"key":"R142-1-20210130","doi-asserted-by":"crossref","first-page":"1917","DOI":"10.1128\/AAC.44.7.1917-1920.2000","article-title":"Evaluation of voriconazole pharmacodynamics using time-kill methodology","volume":"44","author":"Klepser","year":"2000","journal-title":"Antimicrob Agents Chemother"},{"key":"R143-1-20210130","doi-asserted-by":"crossref","first-page":"2014","DOI":"10.1128\/AAC.48.6.2014-2020.2004","article-title":"Effects of voriconazole on Cryptococcus neoformans","volume":"48","author":"van Duin","year":"2004","journal-title":"Antimicrob Agents Chemother"},{"key":"R144-1-20210130","doi-asserted-by":"crossref","first-page":"471","DOI":"10.1128\/AAC.42.2.471","article-title":"In vitro comparative efficacy of voriconazole and itraconazole against fluconazole-susceptible and -resistant Cryptococcus neoformans isolates","volume":"42","author":"Nguyen","year":"1998","journal-title":"Antimicrob Agents Chemother"},{"key":"R145-1-20210130","doi-asserted-by":"crossref","first-page":"3312","DOI":"10.1128\/AAC.48.9.3312-3316.2004","article-title":"Posaconazole and amphotericin B combination therapy against Cryptococcus neoformans infection","volume":"48","author":"Barchiesi","year":"2004","journal-title":"Antimicrob Agents Chemother"},{"key":"R146-1-20210130","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1007\/s11046-006-0039-4","article-title":"Efficacy of voriconazole in experimental Cryptococcus neoformans infection","volume":"162","author":"Mavrogiorgos","year":"2006","journal-title":"Mycopathologia"},{"key":"R147-1-20210130","doi-asserted-by":"crossref","first-page":"162","DOI":"10.1093\/jac\/dkm123","article-title":"Efficacy of voriconazole in a murine model of cryptococcal central nervous system infection","volume":"60","author":"Serena","year":"2007","journal-title":"J Antimicrob Chemother"},{"key":"R148-1-20210130","doi-asserted-by":"crossref","first-page":"728","DOI":"10.1086\/377131","article-title":"Voriconazole concentrations in the cerebrospinal fluid and brain tissue of guinea pigs and immunocompromised patients","volume":"37","author":"Lutsar","year":"2003","journal-title":"Clin Infect Dis"},{"key":"R149-1-20210130","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1080\/13693780400011104","article-title":"Successful therapy of cerebral phaeohyphomycosis due to Ramichloridium mackenziei with the new triazole posaconazole","volume":"43","author":"Al-Abdely","year":"2005","journal-title":"Med Mycol"},{"key":"R150-1-20210130","doi-asserted-by":"crossref","first-page":"745","DOI":"10.1093\/jac\/dki288","article-title":"Activity of posaconazole in the treatment of central nervous system fungal infections","volume":"56","author":"Pitisuttithum","year":"2005","journal-title":"J Antimicrob Chemother"},{"key":"R151-1-20210130","doi-asserted-by":"crossref","first-page":"2641","DOI":"10.1182\/blood-2005-02-0733","article-title":"Improved outcome in central nervous system aspergillosis, using voriconazole treatment","volume":"106","author":"Schwartz","year":"2005","journal-title":"Blood"},{"key":"R152-1-20210130","doi-asserted-by":"crossref","first-page":"e69","DOI":"10.1086\/429319","article-title":"Successful treatment of cerebral blastomycosis with voriconazole","volume":"40","author":"Bakleh","year":"2005","journal-title":"Clin Infect Dis"},{"key":"R153-1-20210130","doi-asserted-by":"crossref","first-page":"751","DOI":"10.1128\/AAC.28.6.751","article-title":"Comparison of amphotericin B and N-D-ornithyl amphotericin B methyl ester in experimental cryptococcal meningitis and Candida albicans endocarditis with pyelonephritis","volume":"28","author":"Perfect","year":"1985","journal-title":"Antimicrob Agents Chemother"},{"key":"R154-1-20210130","doi-asserted-by":"crossref","first-page":"1395","DOI":"10.1016\/0731-7085(95)01566-4","article-title":"Determination of amphotericin B in cerebrospinal fluid by solid-phase extraction and liquid chromatography","volume":"13","author":"Liu","year":"1995","journal-title":"J Pharm Biomed Anal"}],"container-title":["AIDS"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/journals.lww.com\/00002030-200710180-00001","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,4,10]],"date-time":"2021-04-10T07:03:34Z","timestamp":1618038214000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/00002030-200710180-00001"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2007,10]]},"references-count":147,"journal-issue":{"issue":"16","published-print":{"date-parts":[[2007]]}},"URL":"https:\/\/doi.org\/10.1097\/qad.0b013e3282a4a64d","relation":{},"ISSN":["0269-9370"],"issn-type":[{"value":"0269-9370","type":"print"}],"subject":[],"published":{"date-parts":[[2007,10]]}}}